Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2025-12-27 @ 10:37 PM
Study NCT ID:
NCT03989895
Status:
UNKNOWN
Last Update Posted:
2023-07-06
First Post:
2019-06-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma
Sponsor:
PrimeVax Immuno-Oncology Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-12
First Submit QC Date:
None
Study First Post Date:
2019-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-04
Last Update Post Date:
2023-07-06
Last Update Post Date Type:
ACTUAL